BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
275 results:

  • 1. The immune regulation and therapeutic potential of the smad gene family in breast cancer.
    Chen Z; Wang Y; Lu X; Chen H; Kong Y; Rong L; Wang G
    Sci Rep; 2024 Mar; 14(1):6769. PubMed ID: 38514720
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. In-silico and in-vitro evidence suggest LINC01405 as a sponge for miR-29b and miR-497-5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma.
    Norouzi R; Mohamadzade Z; Norouzi R; Norouzi R; Esmaeili R; Soltani BM
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1972. PubMed ID: 38225865
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RSK3 switches cell fate: from stress-induced senescence to malignant progression.
    Huna A; Flaman JM; Lodillinsky C; Zhu K; Makulyte G; Pakulska V; Coute Y; Ruisseaux C; Saintigny P; Hernandez-Vargas H; Defossez PA; Boissan M; Martin N; Bernard D
    J Exp Clin Cancer Res; 2023 Nov; 42(1):318. PubMed ID: 38008756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An NFATc1/smad3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TGF-β1 activates neutrophil signaling and gene expression but not migration.
    Hein LE; SenGupta S; Gunasekaran G; Johnson CN; Parent CA
    PLoS One; 2023; 18(9):e0290886. PubMed ID: 37682817
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. smad3, Cell proliferation and lymph nodes metastasis in breast cancer hormone-dependent.
    Oueslati M; Sassi N; Bettaieb I; Gamoudi A; Rahal K; Oueslati R
    Tunis Med; 2023 Feb; 101(2):273-279. PubMed ID: 37682272
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study.
    Gao Y; Bahl M
    Clin Imaging; 2023 Nov; 103():109979. PubMed ID: 37673705
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
    Lu G; Wang X; Cheng M; Wang S; Ma K
    Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism.
    Fan C; González-Prieto R; Kuipers TB; Vertegaal ACO; van Veelen PA; Mei H; Ten Dijke P
    Sci Signal; 2023 Jun; 16(790):eadf1947. PubMed ID: 37339182
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutational signatures for breast cancer diagnosis using artificial intelligence.
    Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
    J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of smad2/smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
    Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
    Biochem Biophys Res Commun; 2023 Jul; 664():69-76. PubMed ID: 37141640
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.
    Du L; Li J; Tian Y; Feng R
    Cancer Sci; 2023 Jun; 114(6):2429-2444. PubMed ID: 36928924
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
    Le UQ; Chen N; Balasenthil S; Lurie E; Yang F; Liu S; Rubin L; Solis Soto LM; Raso MG; Batra H; Sahin AA; Wistuba II; Killary AM
    Sci Rep; 2022 Nov; 12(1):19504. PubMed ID: 36376460
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.
    Hu J; Huang H; Xi Z; Ma S; Ming J; Dong F; Guo H; Zhang H; Zhao E; Yao G; Yang L; Zhang F; Zheng W; Chen H; Huang T; Li L
    Cell Death Dis; 2022 Sep; 13(9):800. PubMed ID: 36123344
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TGF-β1/smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
    Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
    J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. FA-HA-Amygdalin@Fe
    Abdel-Rafei MK; Askar MA; Azab KS; El-Sayyad GS; El Kodous MA; El Fatih NM; Tawill GE; Thabet NM
    Curr Cancer Drug Targets; 2023; 23(2):118-144. PubMed ID: 35975846
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RNA
    Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
    Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. breast cancer cell-derived extracellular vesicles promote CD8
    Xie F; Zhou X; Su P; Li H; Tu Y; Du J; Pan C; Wei X; Zheng M; Jin K; Miao L; Wang C; Meng X; van Dam H; Ten Dijke P; Zhang L; Zhou F
    Nat Commun; 2022 Aug; 13(1):4461. PubMed ID: 35915084
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with smad4.
    Wang Z; Chen J; Wang S; Sun Z; Lei Z; Zhang HT; Huang J
    Cell Death Dis; 2022 Jul; 13(7):656. PubMed ID: 35902557
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.